Tag: plasma protein-free rFVIII (BAY 81-8973)
Bayer to invest more than 500 million euros for haemophilia A products manufacturing
Bayer, Germany’s biggest pharmaceutical company, has announced that it will invest more than 500 million euros in its Wuppertal and Leverkusen manufacturing sites to...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
